Hyde Park Capital Facilitates Acquisition of Infiniti Medical by CIMA Animal Health

In a major move within the veterinary healthcare sector, Hyde Park Capital has successfully advised Infiniti Medical LLC, along with its subsidiary Orthomed UK Ltd, on their acquisition by CIMA Animal Health. This strategic partnership is set to significantly enhance the offerings in veterinary medicine, ensuring better care for animals across the globe.

Details of the Acquisition

On March 13, 2025, the announcement was made public, revealing the acquisition of two well-established brands renowned for their contributions to veterinary interventional radiology, cardiology, soft tissue surgery, and orthopedics. CIMA Animal Health, a significant player in the veterinary medical solutions arena and part of Incline Equity Partners, is dedicated to the well-being of animals and those who care for them.
Hyde Park Capital’s Managing Director, Craig Lawson, played a pivotal role as the exclusive financial advisor throughout this transaction. Lawson commented on the importance of this deal, emphasizing Infiniti Medical's legacy of innovation and its synergy with CIMA Animal Health’s mission.

Impact on Veterinary Medicine

This acquisition signifies a commitment to continuing innovation in veterinary medicine. CIMA Animal Health’s CEO, Lynn Snodgrass, expressed enthusiasm about the merger, stating, "This acquisition represents an exciting opportunity to expand our impact on veterinary medicine." This collaboration is expected to fast-track the development of advanced solutions, enhancing the quality of veterinary care.

Infiniti Medical has long been a frontrunner in the veterinary health technology field, famous for its groundbreaking Vet Stent technologies and various diagnostic tools, telemedicine applications, and digital health innovations. Additionally, its subsidiary, Orthomed, has built a formidable reputation by providing high-quality orthopedic implants and instruments, establishing new benchmarks in surgical precision for animal healthcare.

Advancing Animal Healthcare

In a statement, Jared Finegold, CEO of Infiniti Medical, emphasized the shared vision of revolutionizing veterinary medicine through advanced technology. He stated, "By partnering with Creative Science, we will continue to scale our efforts, invest further in veterinary medical device innovations, and accelerate our development of cutting-edge technologies and training solutions for veterinarians across the globe."

Hyde Park Capital’s Craig Lawson remarked on the promising future this merger holds, noting the high standard of innovation that both Infiniti Medical and Orthomed have upheld. He reaffirmed Hyde Park’s pride in facilitating this significant transaction, marking a pivotal point in the future of veterinary care.

About the Companies Involved

Infiniti Medical is widely recognized as a leader in veterinary medical technology. Founded in Silicon Valley, it specializes in developing innovative devices and solutions aimed at enhancing animal healthcare. Its contributions, such as the revolutionary Vet Stent technology, have made significant strides in veterinary practices worldwide.

Creative Science, the company formed from a merger of various trusted veterinary brands, aims to bridge critical gaps in patient care—across pets, livestock, and equines. Their mission focuses on providing essential tools to ensure veterinarians, owners, and producers have access to the advancements needed in animal healthcare.

Hyde Park Capital, stationed in Tampa, Florida, is a boutique investment banking firm, focusing on mergers and acquisitions, and has built a strong reputation for customizing financial solutions that meet the needs of founder and family-owned companies in various industries, including healthcare.

Conclusion

This acquisition marks a significant step forward in enhancing veterinary medical solutions, showcasing a commitment to advancing animal healthcare through innovative technology and solutions. As these companies join forces, the veterinary sector can look forward to improved products and services that promise better care for animals worldwide.